Analyze FDA FDF NDC submissions between June and August 2025 to uncover trends, regulatory insights, and what the data reveals about pharma pipelines.Read More
Market intelligence compresses due diligence timelines by bringing supplier data, regulatory signals, and market context together—without cutting corners or increasing risk.Read More
Prices were tracked manually. Decisions were often made based on past relationships, not real-time data. It worked, until it didn’t.Read More
If you work in pharma and you’re not reading audit reports properly, you’re basically asking for trouble.Read More
When a drug’s patent expires, it’s like a door swinging open for generic players, API makers, and formulation experts to rush in. That’s where the real action (and profit) starts.Read More